Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

UN says if US funding for HIV programs is not replaced, millions more will die by 2029 ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

A former official at the Centers for Disease Control and Prevention warns that funding cuts outlined in the proposed fiscal ...

The HIV pandemic still claims a life every minute. While progress has been made, there were 1.3 million new HIV infections ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

As the federal government moves forward with steep cuts to medical and research funding, some in the Bay Area who depend on ...